Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if BCDA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
3 top institutions tracked
Sentiment: bullish
Last trade: buy 15 days ago
Red flags: 0
21 filers reported a long position in BCDA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| CITIGROUP INC | $493K | 397.6K | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $154.5K | 124.6K | Unchanged |
| Pingora Partners LLC | $149.3K | 120.4K | +236.8% |
| UBS Group AG | $96.2K | 77.6K | New |
| GEODE CAPITAL MANAGEMENT, LLC | $82.7K | 66.7K | -29.3% |
| VANGUARD FIDUCIARY TRUST CO | $82.2K | 66.3K | Unchanged |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48.1K | 38.8K | 0% |
| BROWN ADVISORY INC | $44.1K | 35.5K | Unchanged |
| COMMONWEALTH EQUITY SERVICES, LLC | $29K | 23.4K | +27.9% |
| CITADEL ADVISORS LLC | $28.5K | 23K | -63.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.